Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
LATEST POSTS
- 1
Hundreds are quarantined in South Carolina as measles spreads in 2 US outbreaks - 2Doomed SpaceX Starlink satellite photographed from orbit
- 3Insane Realities That Will Make You Reconsider How you might interpret History
- 4Figure out How to Augment the Advantages of a Web-based Degree
- 5Cocoa Prices Sink on Favorable Crop Conditions in West Africa
- NASA chief Jared Isaacman says Texas may get a moonship, not space shuttle Discovery
- New materials, old physics – the science behind how your winter jacket keeps you warm
- The Most Famous Virtual Entertainment Powerhouses of the Year
- Affordable Care Act enrollment is slightly ahead of last year, despite expiring subsidies
- Baby takes 1st steps after receiving groundbreaking gene-edited therapy
- Chicago reports first rabies-positive dog in 61 years. What we know.
- Figure out How to Plan for Your Web-based Degree monetarily
- Incredible Travel Objections for Craftsmanship Darlings to Visit
- The Green Transformation: 5 Feasible Living Practices
